Celldex Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
64.33
|
|
Average Rating
|
4.83
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.58
|
-0.57
|
0.01
|
1.72%
|
|
2022-06-30
|
-0.51
|
-0.77
|
-0.26
|
-50.98%
|
|
2022-03-31
|
-0.45
|
-0.49
|
-0.04
|
-8.89%
|
|
2021-12-31
|
-0.42
|
-0.43
|
-0.01
|
-2.38%
|
|
2021-09-30
|
-0.36
|
-0.45
|
-0.09
|
-25.00%
|
|
2021-06-30
|
-0.40
|
-0.34
|
0.06
|
15.00%
|
|
2021-03-31
|
-0.35
|
-0.42
|
-0.08
|
-21.74%
|
|
2020-12-31
|
-0.37
|
-0.55
|
-0.18
|
-48.65%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.83
|
|
2021-12-31
|
-1.64
|
|
2020-12-31
|
-2.14
|
|
2019-12-31
|
-3.63
|
|
2018-12-31
|
-15.66
|
|
2017-12-31
|
-11.10
|
|
2016-12-31
|
-5.46
|
|
2015-12-31
|
-1.31
|
|
2014-12-31
|
-10.42
|
|
2013-12-31
|
-15.45
|
|
2012-12-31
|
-15.30
|
|
2011-12-31
|
-17.10
|
|
2010-12-31
|
-15.60
|
|
2009-12-31
|
-28.80
|
|
2008-12-31
|
-57.45
|
|
2007-12-31
|
-63.99
|
|
2006-12-31
|
-50.40
|
|
2005-12-31
|
-43.20
|
|
2004-12-31
|
-32.38
|
|
2003-12-31
|
-33.88
|
|
2002-12-31
|
-43.20
|
|
2001-12-31
|
-70.20
|
|
2000-12-31
|
-43.99
|
|
1996-12-31
|
-73.80
|
|
1995-12-31
|
-113.40
|
|
1994-12-31
|
-136.80
|